ARCHIVES

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

This article is from The Cancer Letter archive.

Vol. 32 No. 01 | January 13, 2006

Download PDF Visit The Full Archive

Related Articles

Stone(y) Silence Didn’t Save His Job; Niamd’s Rall Rumored as Top Choice As New NIH Director

December 20, 1974

Pharmacia Corp. Forms $1 Million Fund To Support Anthracycline Research.

June 2, 2000

When Is A Cancer Cured? NCI Suggest One-Year Survival Rates Useful In Determining Advances

August 1, 1975

60-Mile Limit For Primate Facility Dropped

June 9, 1978

Foreign awards Less Than 1% Of NCI Budget

June 22, 1990

Four UICC Programs Available For International Research

July 10, 1981